We are live on ! Find out more
EAM

Erste Asset Management Portfolio holdings

AUM $12.9B
1-Year Est. Return 52.69%
This Fund
S&P 500
This Quarter Est. Return
+10.2%
1 Year Est. Return
+52.69%
3 Year Est. Return
+142.55%
5 Year Est. Return
+182.36%
10 Year Est. Return
AUM
$4.74B
AUM Growth
+$276M
Cap. Flow
-$5.22M
Cap. Flow %
-0.11%
Top 10 Hldgs %
17.82%
Holding
617
New
57
Increased
184
Reduced
143
Closed
49

Sector Composition

Rank Sector Weight
1 Technology 28.76%
2 Healthcare 20.98%
3 Consumer Discretionary 11.7%
4 Financials 9.74%
5 Industrials 8.86%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
BSX icon
426
Boston Scientific
BSX
$63.6B
$478K 0.01%
10,305
-18,850
-65% -$816K
ZLAB icon
427
Zai Lab
ZLAB
$2.78B
$463K 0.01%
15,100
MCK icon
428
McKesson
MCK
$105B
$457K 0.01%
+1,218
New +$454K
HLNE icon
429
Hamilton Lane
HLNE
$5.13B
$453K 0.01%
7,099
-366
-5% -$24.3K
AFYA icon
430
Afya
AFYA
$1.21B
$453K 0.01%
28,191
TWST icon
431
Twist Bioscience
TWST
$9.16B
$448K 0.01%
19,100
BCRX icon
432
BioCryst Pharmaceuticals
BCRX
$2.09B
$447K 0.01%
40,000
OCUL icon
433
Ocular Therapeutix
OCUL
$2.24B
$445K 0.01%
158,800
+63,000
+66% +$209K
KRYS icon
434
Krystal Biotech
KRYS
$9.97B
$431K 0.01%
5,400
DVN icon
435
Devon Energy
DVN
$56.5B
$427K 0.01%
7,000
-3,000
-30% -$204K
PFG icon
436
Principal Financial Group
PFG
$25.3B
$419K 0.01%
4,900
-1,800
-27% -$154K
RVMD icon
437
Revolution Medicines
RVMD
$43.9B
$418K 0.01%
17,400
BCYC
438
Bicycle Therapeutics
BCYC
$257M
$414K 0.01%
14,000
VCYT icon
439
Veracyte
VCYT
$3.23B
$410K 0.01%
17,000
GPK icon
440
Graphic Packaging
GPK
$2.86B
$402K 0.01%
18,000
-20,900
-54% -$460K
MRVI icon
441
Maravai LifeSciences
MRVI
$1.03B
$400K 0.01%
28,400
NIO icon
442
NIO
NIO
$9.02B
$400K 0.01%
40,000
PCRX icon
443
Pacira BioSciences
PCRX
$960M
$382K 0.01%
9,800
BVN icon
444
Compañía de Minas Buenaventura
BVN
$8.44B
$377K 0.01%
+50,000
New +$370K
FICO icon
445
Fair Isaac
FICO
$21.3B
$364K 0.01%
600
P
446
Everpure Inc
P
$32.3B
$363K 0.01%
+13,800
New +$401K
AUTL
447
Autolus Therapeutics
AUTL
$503M
$353K 0.01%
195,000
+75,000
+63% +$190K
CIGI icon
448
Colliers International
CIGI
$4.63B
$346K 0.01%
+3,900
New +$362K
RLAY icon
449
Relay Therapeutics
RLAY
$4.16B
$342K 0.01%
23,100
REPL icon
450
Replimune Group
REPL
$1.23B
$330K 0.01%
11,900

Similar funds

Erste Asset Management's Q4 2022 Portfolio in Review

As of Q4 2022, Erste Asset Management held 617 positions worth $4.74B, up 6.2% from $4.46B the previous quarter. Its ten largest holdings account for 18% of the portfolio.

Erste Asset Management's Q4 2022 filing shows 57 new, 184 increased, 143 reduced and 49 closed positions. Its largest new stake was Kinsale Capital Group: 38,600 shares worth $10.1M. The largest sale was Daqo New Energy, an estimated $22.9M.

By sector, the portfolio is most concentrated in Technology at 29% of assets, down from 29% a quarter earlier, followed by Healthcare and Consumer Discretionary.

  • Erste Asset Management's largest Q4 2022 buy was Kinsale Capital Group: 38,600 shares worth $10.1M.
  • Erste Asset Management added most to Alphabet (Google) Class A in Q4 2022, an estimated $11.2M increase.
  • Erste Asset Management's biggest Q4 2022 reduction was Daqo New Energy, cutting an estimated $22.9M.
  • Erste Asset Management fully exited Diageo in Q4 2022, selling an estimated $7.53M.
  • Erste Asset Management's ten largest holdings make up 18% of its $4.74B portfolio in Q4 2022.
  • Erste Asset Management opened 57 new positions and closed 49 in Q4 2022.
  • Erste Asset Management's portfolio value rose 6.2% quarter-over-quarter to $4.74B.

Based on Erste Asset Management's 13F filing for Q4 2022, filed 26 Nov 2024.